Summary for 9Z7M
| Entry DOI | 10.2210/pdb9z7m/pdb |
| Descriptor | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-[4-[2-azanyl-6-[4-[cyclopropyl(methyl)carbamoyl]phenyl]imidazo[1,2-b]pyridazin-3-yl]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate, SULFATE ION, ... (5 entities in total) |
| Functional Keywords | inhibitor, hydrolase |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 31787.43 |
| Authors | |
| Primary citation | Shiroodi, R.,Montavon, T.J.,Nelson, B.M.,Randolph, J.T.,O'Flynn, D.E.,Iu, L.,Hutchins, C.W.,Baikstis, T.,Izquierdo-Ferrer, J.,Smyth, D.,Krishnan, N.,Maneshi, M.M.,Brown, J.W.,Afanador, G.A.,Jain, R.,Karunan Partha, S.,Bigelow, L.,Nocek, B.,Talaga, L.,Gopalakrishnan, S.M.,Balakrishnan, A.,Sheehan, M.M.,Kurschner, V.A.,Jejurkar, P.C.,Nacham, O.,Hu, D.,Yarilina, A.,Bradley, N.P.,Chapman, A.M.,Thakur, A.,Panchal, S.C.,Sunose, M.,Zoi, I.,Dart, M.J.,Shotwell, J.B.,Benekareddy, M.,Sadowski, R.N.,Swensen, A.M. Discovery of Potent and Orally Bioavailable Novel Cluster of Differentiation 38 (CD38) Small Molecule Inhibitors. J.Med.Chem., 69:13188-13206, 2026 Cited by PubMed Abstract: Herein, we report the discovery and optimization of a series of cluster of differentiation 38 (CD38) inhibitors derived from a virtual ligand screening (VLS) campaign. VLS identified imidazopyridazine hit , which was optimized to a novel and potent CD38 inhibitor peripheral tool () with an excellent pharmacokinetic profile. A cocrystal structure in addition to biophysical and biochemical characterization of is consistent with uncompetitive inhibition of CD38 via the formation of covalent adduct . Further structure- and property-based modifications of afforded sulfuryl pyrazole () with improved CNS distribution properties. Brain-penetrant thienopyrimidine shows robust rodent pharmacokinetics and target engagement across skin, lung, liver, and brain, making it an excellent CD38 tool for the study of indications requiring engagement of CD38 in the brain. PubMed: 42178680DOI: 10.1021/acs.jmedchem.6c00171 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.84 Å) |
Structure validation
Download full validation report






